Literature DB >> 15995438

Cruciate-retaining total knee arthroplasty at 5 to 7 years followup.

Kim C Bertin1.   

Abstract

UNLABELLED: Cruciate-retaining total knee implants may improve postoperative function in total knee arthroplasty, but whether patients experience good restoration of kinematics, undue wear, or increased revision rates is debatable. I evaluated clinical results, radiographs, and survival rates of the NexGen posterior cruciate-retaining implant at 5-7 years followup in 251 knees (198 patients) in a prospective, consecutive total knee replacement series done from 1996-1997. A consistent improvement in knee scores and range of motion was observed from preoperative evaluation through 5 years followup. Alignment remained constant and knee stability did not deteriorate. Knee Society scores were good or excellent for 90% of patients. The average range of motion was 123 degrees, and 73% of patients achieved a mean range of motion of 116 degrees -130 degrees. Mean physical quality of life measures improved from preoperative evaluation to the last followup. There were no complete or progressive radiolucencies. Four screw radiolucencies had progressive increases in diameter. Survival of the implant at 7 years was more than 98%. The NexGen posterior cruciate-retaining implant provided satisfactory kinematic and clinical results with no substantive polyethylene wear. LEVEL OF EVIDENCE: Therapeutic study, Level II-2 (poor-quality randomized controlled trial). See the Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2005        PMID: 15995438     DOI: 10.1097/01.blo.0000160381.23052.34

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  8 in total

1.  Osteolysis in well-functioning fixed- and mobile-bearing TKAs in younger patients.

Authors:  Young-Hoo Kim; Yoowang Choi; Jun-Shik Kim
Journal:  Clin Orthop Relat Res       Date:  2010-04-01       Impact factor: 4.176

2.  Knee arthroplasty with a medially conforming ball-and-socket tibiofemoral articulation provides better function.

Authors:  Fahad Hossain; Shelain Patel; Shin-Jae Rhee; Fares Sami Haddad
Journal:  Clin Orthop Relat Res       Date:  2011-01       Impact factor: 4.176

3.  High-flexion prosthesis improves function of TKA in Asian patients without decreasing early survivorship.

Authors:  Bum-Sik Lee; Jong-Won Chung; Jong-Min Kim; Kyung-Ah Kim; Seong-Il Bin
Journal:  Clin Orthop Relat Res       Date:  2013-05       Impact factor: 4.176

4.  In vivo flexion and kinematics of the knee after TKA: comparison of a conventional and a high flexion cruciate-retaining TKA design.

Authors:  Jeremy F Suggs; Young-Min Kwon; Sridhar M Durbhakula; George R Hanson; Guoan Li
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-10-07       Impact factor: 4.342

5.  Clinical, Functional, and Midterm Survival Analysis on Sigma Curved Plus Ultracongruent Polyethylene Insert in Primary Total Knee Arthroplasty: A Retrospective Study.

Authors:  Neelam Reddy; Mukesh K Saini; Gattu Naresh; Ajay Thakur; Rajesh Podili; Jayavardhan Reddy
Journal:  Cureus       Date:  2020-11-17

6.  Results of Total Knee Arthroplasty with NexGen LPS-flex Implant Using Navigation System (Brain Lab): Results with a 5-year Follow-up.

Authors:  Chul Hyung Kang; Kyung Jae Lee; Ki Cheor Bae; Chul Hyun Cho; Si Wook Lee; Hong Kwan Shin; Young Kook Lee; Ji Suk Bae
Journal:  Knee Surg Relat Res       Date:  2012-11-29

7.  Outcomes of the different types of total knee arthroplasty with the identical femoral geometry.

Authors:  Sang Min Lee; Sang Cheol Seong; Sahnghoon Lee; Won Chul Choi; Myung Chul Lee
Journal:  Knee Surg Relat Res       Date:  2012-11-29

8.  Clinical and radiological results of cruciate-retaining total knee arthroplasty with the NexGen®-CR system: comparison of patellar resurfacing versus retention with more than 14 years of follow-up.

Authors:  Keun Churl Chun; Sung Hyun Lee; Jong Seok Baik; Seng Hwan Kook; Joung Kyue Han; Churl Hong Chun
Journal:  J Orthop Surg Res       Date:  2017-10-02       Impact factor: 2.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.